Researchers identified 36 genes linked to obsessive-compulsive and chronic tic disorders, revealing shared biological pathways and potential targets for novel therapeutics. Separately, blocking the mitochondrial protein EFHD1 reduced fatty liver injury and scarring in preclinical models, supporting a potential drug development strategy.
